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Abstract: Insulin resistance (IR) is accompanied by increased areal or volumetric bone mineral density
(aBMD or vBMD), but also higher fracture risk. Meanwhile, imbalances in bone health biomarkers
affect insulin production. This study investigates the effect of IR on proximal femur and lumbar spine
BMD, femoral neck bending, compressive and impact strength indices (Composite Strength Indices)
and circulating levels of parathyroid hormone (PTH), C-telopeptide of Type I collagen (CTx-1) and
25(OH) Vitamin D3, in a cohort of 97 healthy, non-obese, menopausal Chinese-Singaporean women.
Lumbar spine aBMD was inversely associated with IR and dependent on lean body mass (LBM) and
age. No such associations were found for vBMD of the third lumbar vertebra, aBMD and vBMD
of the proximal femur, or circulating levels of PTH, CTx-1 and 25(OH) Vitamin D3. Composite
Strength Indices were inversely associated with IR and independent of LBM, but after adjusting for
fat mass and age, this association remained valid only for the impact strength index. Composite
Strength Indices were significantly lower in participants with a high degree of IR. Our findings on IR
and Composite Strength Indices relationships were in agreement with previous studies on different
cohorts, but those on IR and BMD associations were not.
Keywords: insulin resistance; HOMA-IR; DXA; QCT; BMD; Composite Strength Indices; parathyroid
hormone (PTH); 25(OH) Vitamin D3; CTx-1
1. Introduction
The relationship between Type 2 diabetes mellitus (T2DM) and bone strength—a product of bone
mineral density (BMD), geometry and architecture—is complex. People with T2DM have higher BMD,
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compared to people without the condition, but they also have increased risk of bone fractures [1].
Considering the rise of T2DM globally [2], and the fact that bone fractures cause high rates of morbidity
and mortality [3], a better understanding of the relationship between T2DM and bone strength is an
important step toward preventing fragility fractures as a complication of T2DM.
Studies suggest that insulin resistance (IR), one of the main drivers of T2DM, plays a direct role in
the increased BMD of people with this condition [4,5]. Insulin, a hormone secreted by the pancreas,
is involved in the absorption of glucose by cells. Insulin resistance leads to inefficient use, and thus
elevated circulating levels, of insulin. It has been proposed that insulin has anabolic effects on bone [6]
and that, in turn, bone may play a role in the regulation of insulin sensitivity [7]. On the one hand,
osteoblasts, bone cells responsible for the synthesis and mineralization of bone, express the insulin
receptor which, when activated by insulin, triggers bone resorption [8]. On the other hand, deletion
of the insulin receptor in osteoblasts has been shown to result in insulin resistance and obesity,
and osteocalcin, a protein secreted by osteoblasts, promotes insulin synthesis and can regulate insulin
sensitivity [9]. Meanwhile, disruption of bone remodeling pathways also affects insulin sensitivity.
For example, changes in parathyroid hormone (PTH) levels, a hormone involved in bone remodeling,
and Vitamin D deficiency, an important nutrient in bone metabolism, affect the synthesis and release
of insulin [7]. Biomarkers of bone formation (P1NP, osteocalcin) and bone resorption (C-telopeptide of
Type I collagen-CTx-1) are lower in people with T2DM, compared to people without the condition [5].
The association of body mass index (BMI) and fracture risk has been shown to depend on BMD [10],
while high BMI, common in people with IR, has been associated with high BMD. This increase
is proportional to lean body mass (LBM) rather than fat mass (FM) or total body mass [11,12], as
the dynamic stresses applied on the bones by muscle, but not the static load of fat mass, are thought
to stimulate bone formation. Furthermore, studies on cohorts that differ in age, gender and ethnicity,
reproductive stages in women (pre-, peri- or post-menopause) and use of diabetes medications have
led to varying conclusions regarding the relationship between IR and BMD [13,14].
Studies of the effect of IR on the strength of the femoral neck, described by Composite Strength
Indices [15], have shown an inverse association of femoral neck strength and insulin resistance [13,16].
Femoral neck strength has also been shown to depend on FM, rather than LBM, in women with
non-insulin-requiring T2DM, while LBM, and not FM, was a predictor in a group of men with the same
characteristics [17].
The aim of this study was to investigate the effect of IR on bone mineral density of the proximal
femur and the lumbar spine, as well as on femoral neck strength, CTx-1, PTH and 25(OH) Vitamin D3
concentration levels in healthy, non-obese, menopausal Chinese-Singaporean women. We examined
areal and volumetric BMD (aBMD and vBMD, respectively) of the proximal femur and the lumbar
spine. In order to examine if IR affects each bone component differently, both whole-bone and
compartment-specific vBMD of the proximal femur were measured. Based on previous findings from
literature, we hypothesized that bone mineral density is positively associated with IR, while femoral
neck strength and bone turnover are inversely associated with IR.
2. Materials and Methods
2.1. Cohort Characteristics
A total of 97 healthy, non-obese menopausal Chinese-Singaporean women were examined.
The participants were between 55 and 70 years of age, at least 5 years menopausal, based on cessation
of menstruation (spontaneous or otherwise), and had BMI between 18 and 28 kg/m2. None of
the participants had been previously diagnosed with osteoporosis or other bone disease, diabetes
or any medical condition which affects bone and liver metabolism. The participants did not smoke
or drink more than 2 units of alcohol daily and were not taking medications that could affect bone
health. The study was given ethical approval by the National Healthcare Group (Singapore), indexed
in www.clinicaltrials.gov (NCT 03309254) and all participants provided informed written consent.
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2.2. Anthropometric Data
The participants reported their age and years since menopause. The height (m), weight (kg), waist
and hip circumference (cm) were measured and the BMI was calculated as the ratio of weight and
squared height (kg/m2).
2.3. Biochemical Measurements
Blood and urine samples were collected from the participants after an overnight 12-h fast. Fasting
and post-prandial blood samples that were collected from the test session were centrifuged at 1500× g
for 10 min, and plasma aliquots were sent to National University Hospital, Singapore, Referral
Laboratory for insulin and glucose measurements. Insulin was measured using the Cobas e411
(Roche Diagnostics, Switzerland). Glucose was measured using a photometric assay, hexokinase
method. Plasma samples were also frozen, stored in dry ice and sent to Massey University, New
Zealand. From there, the frozen samples were forwarded to Canterbury Health Laboratories, New
Zealand, for analysis. Parathyroid hormone (PTH) and C-telopeptide of Type I collagen (CTx-1) were
analyzed by electrochemiluminescence immunoassay using the Roche COBAS® e411 system (Roche
Diagnostics, Indianapolis, IN, USA). 25 (OH) Vitamin D3 was analyzed using isotope-dilution liquid
chromatography-tandem mass spectrometry (ID-LC-MS-MS), as an indicator of Vitamin D status.
The gold standard method for measuring insulin resistance is the glucose clamp technique [18],
which is costly, invasive and time-consuming. In this study, the homeostasis model assessment of
insulin resistance (HOMA-IR) [19] was used to assess the level of insulin resistance from fasting insulin
(FI) and fasting glucose (FG) levels, (FI [mIU/L]·FG [mmol/L]/22.5). HOMA-IR is strongly associated
with the glucose clamp technique [20] and higher values indicate higher insulin resistance [21].
The fasting blood glucose of one participant was outside the normal range (>7 mmol/L) and data
acquired was thus excluded from further analysis. Unless otherwise stated, data from 96 participants
was available.
2.4. Body Composition and Areal Bone Mineral Density (aBMD)
Body composition (percentage of body fat, FM and LBM) and areal bone mineral density (aBMD)
of the lumbar spine (L1–L4), the femoral neck and total hip of the non-dominant leg were measured by
means of dual X-ray absorptiometry (DXA, Hologic Discovery QDR 4500A densitometer, Hologic Inc.
Bedford, MA, USA).
2.5. Volumetric Bone Mineral Density (vBMD)
Volumetric quantitative computed tomography (QCT) of both proximal femurs and the third
lumbar vertebra (L3) was performed in a clinical CT scanner (Siemens mCT, Erlangen, Germany)
using a commercial phantom (Mindways Software Inc., Austin, TX, USA). Peak kilovoltage was
120 kVp and tube current was 200 mAs for the proximal femurs and 100 mAs for L3. All scans were
analyzed using the phantom manufacturer’s standard software (QCT Pro, version 5.0). vBMD of
the trabecular bone compartment of L3 was measured, as well as of the whole bone and of the different
compartments (cortical and trabecular) of the femoral neck and the total hip of the non-dominant leg.
Femoral neck width (FNW), hip axis length (HAL) and DXA-equivalent aBMD of the whole bone and
the separate bone compartments of the femoral neck and the total hip were calculated from projections
of the proximal femur. The ratio of cortical bone to whole bone in the proximal femur was calculated
from the QCT measurements during analysis. Volumetric BMD measurements of the proximal femur
were invalid for one of the participants, due to incorrect automatic placement of the regions of interest.
As a result, QCT data was available for 95 participants.
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2.6. Femoral Neck Strength
The strength of the femoral neck was assessed using Composite Strength Indices, a set of indices
that take into account aBMD, geometric characteristics of the proximal femur (FNW, HAL) and
anthropometric characteristics of the participant (weight, height), to estimate femoral neck strength
under different loads as follows [15].
Compression strength index CSI =
aBMD · FNW
Weight
Bending strength index BSI =
aBMD · FNW2
HAL × Weight
Impact strength index ISI =
aBMD · FNW × HAL
Height × Weight
All three indices were recorded in units of gkg·m . The compression strength index (CSI) is a measure
of the ability of the femoral neck to withstand compressive load in the axial dimension, the bending
strength index (BSI) is a measure of its ability to withstand bending forces and ISI is a measure of its
ability to absorb the energy of a fall from standing height. FNW and HAL were unavailable for two
participants, for which Composite Strength Indices were not calculated. In total, sets of Composite
Strength Indices for 94 participants were available.
2.7. Statistical Analysis
Statistical analysis was performed using SPSS for Windows, version 24.0 (SPSS Inc., Chicago, IL,
USA). The values are presented in terms of average value and standard deviation.
Linear relationships between insulin resistance and bone strength, as well as biomarkers in
blood, were assessed by means of univariate regression analysis between HOMA-IR and bone-related
variables over the entire cohort. The distribution of HOMA-IR values is not normal, thus its
log-transformed values were used for analysis instead. As discussed earlier, LBM has been shown to
affect BMD and FM has an effect on Composite Strength Indices, while age has also a negative effect
on bone strength. In order to isolate the effect of insulin resistance from these parameters, LBM and
age were also added to the regression model, and in the case of Composite Strength Indices, models
that include FM in the place of LBM were also examined.
Subsequently, the participants were divided into three groups according to HOMA-IR, using
the cut-off values reported in [22]. These cut-off values were calculated using data from a cohort
of Chinese menopausal women, to distinguish between women with healthy glucose metabolism
(HOMA-IR < 1.37), dysglycemia (1.37 ≤ HOMA-IR < 1.97) and T2DM (HOMA-IR ≥ 1.97). Since
the cohort in the present study did not include participants with T2DM, these cut-off values were
used in our analysis to separate the participants into groups with different levels of insulin resistance.
Two-tailed t-tests showed no statistically significant differences between the bone-related parameters
in the two groups with higher insulin resistance (HOMA-IR ≥ 1.37). Thus, participants belonging to
these groups were pooled into one “high HOMA-IR” group and two-tailed t-tests were performed
between the “low HOMA-IR” (HOMA-IR < 1.37) and “high HOMA-IR” groups, to look for potential
inter-group differences in aBMD and vBMD of the lumbar spine, aBMD, vBMD, cortical to total bone
ratio in the proximal femur, as well as in the Composite Strength Indices of the femoral neck and
bone turnover markers. Values of p < 0.05 were considered significant. Analysis was performed on
the available data of each parameter.
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3. Results
3.1. Cohort Characteristics
After combining the two groups with higher HOMA-IR, 60 participants belonged in the “low
HOMA-IR” group and 36 in the “high HOMA-IR” group. The average age, height and years since
menopause did not differ significantly between the two groups, but weight, LBM, FM and BMI did
(p < 0.01) (Table 1).
Table 1. General characteristics of the total study population, “Low HOMA-IR” and “High HOMA-IR”
groups and p values calculated by means of two-tailed t-tests between the two HOMA-IR groups.
All Subjects Low HOMA-IR High HOMA-IR p
N (Group Size) 96 60 36
Age (years) 60.70 ± 4.17 60.80 ± 4.30 60.50 ± 3.99 0.76
Years menopausal 10.60 ± 6.04 10.20 ± 6.00 11.33 ± 6.15 0.39
Weight (kg) 55.90 ± 7.25 54.20 ± 6.26 58.78 ± 7.96 <0.01*
Height (m) 1.56 ± 0.05 1.56 ± 0.06 1.56 ± 0.05 0.94
Body mass index (BMI) (kg/m2) 22.90 ± 2.69 22.20 ± 2.44 24.03 ± 2.76 <0.01*
Fat Mass (kg) 21.90 ± 4.96 20.86 ± 4.25 23.62 ± 5.62 <0.01*
Lean Body Mass (kg) 31.59 ± 3.10 30.93 ± 2.88 32.69 ± 3.19 <0.01*
Fasting glucose (mmol/L) 4.90 ± 0.46 4.80 ± 0.41 5.04 ± 0.51 <0.05*
Fasting Insulin (mIU/L) 6.20 ± 3.05 4.40 ± 1.21 9.25 ± 2.70 <0.01*
HOMA-IR 1.36 ± 0.71 0.93 ± 0.27 2.07 ± 0.64 <0.01*
p: significance level between Low HOMA-IR group and High HOMA-IR group. * p < 0.05.
3.2. Associations between Bone Strength Parameters and Homeostasis Model Assessment of Insulin Resistance
(HOMA-IR)
The results of univariate and multivariate linear regression analysis, in terms of standardized
β-coefficients and significance level, for log10(HOMA-IR) and R-squared of the model are shown
in Table 2. Univariate linear regression analysis resulted in no statistically significant relationship
between HOMA-IR and aBMD (DXA and QCT), vBMD (total, cortical and trabecular) of the proximal
femur, trabecular bone vBMD of L3 or the cortical to total bone volume ratio in the proximal femur.
No statistically significant relationships were observed between HOMA-IR and CTx-1, PTH or 25(OH)
Vitamin D3 levels, either. However, the relationships between the Composite Strength Indices and
HOMA-IR were statistically significant; HOMA-IR could be attributed with 13% of the variation in
CSI, 6.8% of the variation in BSI and 15.8% of the variation in ISI in the femoral neck.
The relationships between HOMA-IR and Composite Strength Indices remained significant after
LBM was added to the regression model. This model explains 14.3%, 8.3% and 16.2% of the variation
in CSI, BSI and ISI, respectively. The relationship between DXA aBMD in the lumbar spine and
HOMA-IR became stronger (p = 0.05); this model explains 17.2% of the variation in lumbar spine
aBMD. The relationship between HOMA-IR and trabecular vBMD of L3 was strengthened as well,
although the result is still not statistically significant (p = 0.087).
Adding age as a third independent variable to the model resulted in a statistically significant
relationship between lumbar spine aBMD and HOMA-IR. The relationship of HOMA-IR and
Composite Strength Indices of the femoral neck remained significant. This model explains 18.9%
of the variation in lumbar spine aBMD and 18.6%, 11.2% and 19.7% of the variation in CSI, BSI and
ISI, respectively. The relationship between HOMA-IR and trabecular vBMD of L3 was strengthened,
although the result was still not statistically significant (p = 0.075).
Adjusting for FM instead of LBM resulted in a loss of significance for the relationship between
HOMA-IR and Composite Strength Indices, although the association of ISI with HOMA-IR was
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marginally significant (p = 0.052). Significance was achieved only for ISI after further adjusting for age
(p = 0.039); this model explains 29.5% of the variation in ISI.
Table 2. Results of univariate and multivariate linear regression analysis between log10HOMA-IR and
areal BMD (aBMD), volumetric BMD (vBMD), cortical bone ratio, Composite Strength Indices and
blood markers.
Unadjusted Adjusted for LBM Adjusted for LBM and Age
β p R2 β p R2 β p R2
DXA aBMD
Femoral neck 0.054 0.604 0.003 −0.064 0.540 0.113 −0.064 0.531 0.162
Total hip 0.000 0.997 0.000 −0.096 0.365 0.075 −0.096 0.359 0.111
Lumbar spine −0.053 0.605 0.003 −0.199 0.050 0.172 −0.199 0.049 0.189
QCT aBMD
Femoral neck
total −0.062 0.549 0.004 −0.144 0.185 0.057 −0.144 0.177 0.097
cortical −0.047 0.648 0.002 −0.103 0.350 0.027 −0.103 0.346 0.050
trabecular 0.008 0.942 0.000 −0.050 0.645 0.027 −0.051 0.644 0.041
Total hip
total −0.015 0.888 0.000 −0.097 0.367 0.055 −0.098 0.358 0.095
cortical −0.044 0.671 0.002 −0.103 0.349 0.029 −0.103 0.337 0.083
trabecular 0.086 0.410 0.007 −0.013 0.899 0.085 −0.013 0.900 0.087
QCT vBMD
Femoral neck
total −0.046 0.659 0.002 −0.065 0.557 0.005 −0.065 0.555 0.026
cortical 0.085 0.415 0.007 0.088 0.426 0.007 0.088 0.416 0.052
trabecular −0.019 0.855 0.000 −0.022 0.840 0.000 −0.023 0.837 0.031
cort.vol/tot.vol −0.093 0.369 0.009 −0.114 0.301 0.012 −0.114 0.293 0.054
Total hip
total −0.006 0.956 0.000 −0.003 0.976 0.000 −0.003 0.975 0.040
cortical −0.049 0.636 0.002 −0.107 0.329 0.029 −0.107 0.328 0.047
trabecular 0.040 0.703 0.002 0.023 0.835 0.004 0.023 0.836 0.015
cort.vol/tot.vol −0.070 0.500 0.005 −0.048 0.666 0.009 −0.048 0.666 0.016
L3 vertebra
trabecular −0.140 0.175 0.020 −0.187 0.087 0.037 −0.187 0.075 0.120
Composite Strength Indices
CSI −0.360 0.000* 0.130 −0.319 0.003* 0.143 −0.320 0.002* 0.186
BSI −0.261 0.011* 0.068 −0.219 0.042* 0.083 −0.220 0.039* 0.112
ISI −0.397 0.000* 0.158 −0.373 0.000* 0.162 −0.374 0.000* 0.197
Bone Turnover Markers
CTx-1 0.071 0.491 0.005 0.064 0.561 0.005 0.064 0.562 0.009
25(OH) Vitamin D3 −0.002 0.984 0.000 0.028 0.798 0.007 0.028 0.798 0.024
PTH 0.109 0.291 0.012 0.030 0.780 0.062 0.030 0.780 0.069
LBM: lean body mass, β: standardized β-coefficient, p: significance level, R2: R-squared of the model; DXA: dual
X-ray absorptiometry, QCT: quantitative computed tomography, cort.vol/tot.vol: cortical to total volume ratio; CSI:
compression strength index, BSI: bending strength index, ISI: impact strength index, CTx-1: C-telopeptide of Type I
collagen, PTH: parathyroid hormone. * p < 0.05.
3.3. Comparison of Bone Strength Parameters between “High HOMA-IR” and “Low HOMA-IR” Groups
The average values and standard deviations of the examined parameters of each group and
the p-values of two-tailed t-tests between the two HOMA-IR groups are shown in Table 3. aBMD in
the lumbar spine and trabecular vBMD in the L3 vertebra was lower in the “high HOMA-IR” group,
but the differences were only marginally significant (p < 0.1). No statistically significant differences
were observed in the aBMD, vBMD or cortical to total bone volume ratio of the proximal femur
between the two groups. Participants in the “high HOMA-IR” group had lower values of CSI (p < 0.01),
BSI (p < 0.05) and ISI (p < 0.01) in the femoral neck. None of the blood biomarkers examined showed
statistically significant differences between the two groups, although CTx-1 was higher in the “high
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HOMA-IR” group (p = 0.067). Considering that the association between CTx-1 and HOMA-IR appears
to be statistically insignificant in univariate and multivariate linear regression analysis (Table 2),
the marginal statistical significance in CTx-1 concentration between the two groups implies that this
association is stronger in the separate groups than in the whole cohort. Indeed, univariate regression
analysis with log10HOMA-IR as the independent variable showed marginally significant associations
between HOMA-IR and CTx-1 in the “low HOMA-IR” group (p = 0.068, stand. beta coefficient =
−0.237) and the “high HOMA-IR” group (p = 0.088, stand. beta coefficient = 0.015), which means that
an increase of one standard deviation in log10HOMA-IR, will lead to a decrease of 0.237 standard
deviations in the concentration of CTx-1 in the “low HOMA-IR” group, and to a minor increase of
0.015 standard deviations in the “high HOMA-IR” group.
Table 3. Average values and standard deviations of parameters in “low HOMA-IR” and “high
HOMA-IR” groups and p-values of two-tailed t-tests between the two groups.
Low HOMA-IR Group High HOMA-IR Group p
DXA aBMD
Femoral neck (g/cm2) 0.64 ± 0.09 0.64 ± 0.08 0.978
Total hip (g/cm2) 0.79 ± 0.11 0.78 ± 0.09 0.536
Lumbar spine (g/cm2) 0.87 ± 0.14 0.85 ± 0.13 0.404
QCT aBMD
Femoral neck
total (g/cm2 K2HPO4) 0.69 ± 0.11 0.66 ± 0.09 0.160
cortical (g/cm2 K2HPO4) 0.44 ± 0.11 0.42 ± 0.07 0.299
trabecular (g/cm2 K2HPO4) 0.24 ± 0.03 0.24 ± 0.04 0.377
Total hip
total (g/cm2 K2HPO4) 0.75 ± 0.12 0.72 ± 0.10 0.257
cortical (g/cm2 K2HPO4) 0.46 ± 0.11 0.43 ± 0.08 0.169
trabecular (g/cm2 K2HPO4) 0.28 ± 0.03 0.29 ± 0.04 0.683
QCT vBMD
Femoral neck
total (mg/cm3 K2HPO4) 312.58 ± 56.31 301.46 ± 36.53 0.294
cortical (mg/cm3 K2HPO4) 982.96 ± 113.00 998.28 ± 109.29 0.518
trabecular (mg/cm3 K2HPO4) 139.44 ± 19.42 134.77 ± 19.70 0.261
cortical to total volume ratio 0.21 ± 0.07 0.20 ± 0.05 0.266
Total hip
total (mg/cm3 K2HPO4) 277.32 ± 59.01 270.17 ± 37.19 0.516
cortical (mg/cm3 K2HPO4) 926.69 ± 85.80 924.89 ± 76.49 0.918
trabecular (mg/cm3 K2HPO4) 133.29 ± 17.45 131.23 ± 17.76 0.580
cortical to total volume ratio 0.22 ± 0.24 0.18 ± 0.04 0.294
L3 vertebra
trabecular (mg/cm3 K2HPO4) 109.08 ± 24.55 99.86 ± 28.79 0.098
Composite strength indices
CSI (g/(kg×m)) 3.56 ± 0.61 3.16 ± 0.57 0.002*
BSI (g/(kg×m)) 0.99 ± 0.22 0.89 ± 0.19 0.019*
ISI (g/(kg×m)) 0.23 ± 0.04 0.20 ± 0.04 0.001*
Bone Turnover Markers
CTx-1 (µg/L) 0.51 ± 0.18 0.60 ± 0.30 0.067
25(OH)D3 (nmol/L) 59.03 ± 14.65 60.33 ± 14.30 0.672
PTH (pmol/L) 4.65 ± 1.26 5.24 ± 3.30 0.218
p: significance level, cort.vol/tot.vol: cortical to total volume ratio; CSI: compression strength index, BSI: bending
strength index, ISI: impact strength index. * p < 0.05.
4. Discussion
This is the first study to investigate the association of insulin resistance with bone strength and
bone turnover in healthy, non-obese, menopausal Chinese-Singaporean women. The proximal femur
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and the lumbar spine were examined, as these are two anatomical sites at high risk of osteoporotic
fractures. aBMD and vBMD of these sites and Composite (compressive, bending and impact) Strength
Indices of the femoral neck were investigated as measures of bone strength, while PTH, CTx-1 and
25(OH) Vitamin D3 were examined as blood biomarkers related to bone health. vBMD was measured
for the whole bone, as well as its separate components, so as to examine the possible effect of IR in each
one. The HOMA-IR index was used for the calculation of insulin resistance. A statistically significant,
negative relationship of HOMA-IR and lumbar spine (L1–L4) aBMD was observed after controlling for
LBM and age. No significant associations were observed between HOMA-IR and aBMD or vBMD
in the proximal femur, but a statistically significant, negative association was observed between
HOMA-IR and all Composite Strength Indices of the femoral neck. Although these relationships
remained largely unaffected by LBM and age, significance was lost for the compressive and bending
strength indices, but not for the impact strength index, after controlling for FM and age. PTH, CTx-1
and 25(OH) Vitamin D3 were not associated with HOMA-IR in the models used. All Composite
Strength Indices were significantly lower in the “high HOMA-IR” group, compared to the “low
HOMA-IR” group.
The relationship between insulin resistance and BMD has been studied in different populations
with mixed results. In a study of menopausal, Caucasian women without diabetes [14], aBMD
in the total hip and the lumbar spine showed a statistically significant, positive correlation with
HOMA-IR, which disappeared after adding body weight to the model. Meanwhile, in a diverse
cohort—relative to age, gender, race, status of diabetes and menopause—after adjusting for those
factors and BMI, HOMA-IR was not associated with aBMD of the femoral neck, but was positively
associated with lumbar spine aBMD [13]. Finally, in a cohort of South Korean men, HOMA-IR was
negatively associated with total body, femoral neck and lumbar spine aBMD, after adjusting for factors
such as age, height, weight, percentage of fat mass and lifestyle factors [23]. The primary difference
between our study and those mentioned above is the population represented by the cohort. This
implies that differences in gender, age and race affect the relationship between insulin resistance
and BMD. Of the BMD measurements examined in our study, HOMA-IR was only associated with
aBMD in the lumbar spine. The association was negative, and only reached statistical significance after
controlling for LBM and age. vBMD of L3 was also negatively associated with HOMA-IR in the same
regression model, but this relationship was only marginally significant (p = 0.075). No statistically
significant differences between the aBMD and vBMD measurements of the high- and low- HOMA-IR
groups were observed in either anatomical site, although differences in trabecular vBMD of L3 were of
marginal statistical significance (p = 0.098). These results suggest that insulin resistance has a different
effect on menopausal Chinese women without T2DM than their Caucasian counterparts, but a similar
effect as on the aBMD of Asian men.
The negative associations observed between HOMA-IR and Composite Strength Indices of
the femoral neck were in accordance with those already reported in a number of different cohorts.
In [13], the cohort included both men and women of varying ages, different ethnic groups and diabetes
status, among others. In [16], the cohort consisted of pre- and peri-menopausal women of diverse
ethnic groups and varying diabetes status. Although our study did not include participants with
diabetes, all three Composite Strength Indices exhibited a negative association with HOMA-IR and
significant differences between the two HOMA-IR groups. Controlling for LBM and age made small
difference in the model, which implies that LBM does not affect femoral neck strength. This result is in
accordance with the findings in [17], where, in a cohort of women with non-insulin-requiring T2DM,
LBM was not a predictor of section modulus and buckling ratio. These parameters describe bending
strength and hip cortical stability under compressive load, as measured by means of hip structure
analysis [24]. Interestingly, in the aforementioned study, FM was a predictor of the strength parameters
in women, while LBM, and not FM, was a predictor in a group of men with the same characteristics.
In our study, controlling for FM instead of LBM resulted in a non-significant association between
HOMA-IR and Composite Strength Indices; significance was reached only for the impact strength
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index (ISI), after further controlling for age. These findings indicate that in our cohort, FM, and not
LBM, affects the relationship between insulin resistance and femoral neck strength, in accordance with
existing literature.
Vitamin D deficiency is known to impair the release and action of insulin [7]. Higher levels of
Vitamin D correlated negatively with insulin resistance in a cohort of Chinese men and women with
T2DM [25], while raising Vitamin D levels in South Asian women with insulin resistance has been
shown to improve insulin sensitivity [26]. Fasting PTH levels have been found to be inversely related
to insulin sensitivity, as measured during a hyperglycemic clamp test in healthy, insulin-sensitive
individuals [27], while in obese girls, PTH was negatively associated with HOMA-IR [28]. In [4],
CTx-1 levels were higher in groups of (both lean and obese) insulin-sensitive people than in groups of
obese people with insulin resistance (with or without T2DM). In our study, 25(OH) Vitamin D3 (an
indicator of Vitamin D status), PTH and CTx-1 concentrations were not significantly associated with
HOMA-IR. There were no statistically significant differences in these biomarkers between the high-
and low- HOMA-IR groups either. Interestingly, however, the difference in CTx-1 concentrations
between the two HOMA-IR groups was marginally significant (p = 0.067). This result was explained
by the strong associations—still of no statistical significance—between CTx-1 and HOMA-IR in
the separate groups. In [4], participants with insulin resistance had lower levels of CTx-1 than
insulin-sensitive participants, and CTx-1 concentrations in insulin-resistant states could not be
suppressed further. In our study, the “low HOMA-IR” group had lower concentrations of CTx-1
than the “high HOMA-IR” group. The discrepancy between our findings and findings in literature can
be attributed to the different profile of our cohort; our participants were all non-obese, menopausal
Chinese-Singaporean women without T2DM and in good health. Moreover, since CTx-1 is a bone
resorption marker, its lower levels in the “low HOMA-IR” group are in agreement with the negative
association between HOMA-IR and aBMD in the lumbar spine.
Our study had several limitations. The participants were separated in groups according to
the cut off values reported in [22], which do not necessarily mirror their actual insulin-sensitivity
status, of which we have no knowledge. No measurements of osteocalcin and P1NP were available,
which would have given an insight into bone formation in relation to insulin resistance. Additionally,
only a snapshot of the glycemic status of the participants is available, as fasting levels of glucose
and insulin were used for analysis. An oral glucose tolerance test would have given more concrete
information about the insulin sensitivity of the participants, while the sampling of blood during a
glucose clamp challenge would have given dynamic information about the relationship of blood
markers and insulin resistance.
5. Conclusions
We have shown that in healthy, non-obese, menopausal Chinese-Singaporean women without
Type 2 diabetes melitus, the level of insulin resistance does not affect the bone mineral density of
the proximal femur, while the relationship between aBMD of the lumbar spine and insulin resistance
is negative and depends on lean body mass and age. Femoral neck strength is inversely related to
insulin resistance and is strongly dependent on fat mass, rather than lean mass, and age. Circulating
concentrations of 25(OH) Vitamin D3, PTH and CTx-1 are not significantly associated with insulin
resistance. Femoral neck strength was shown to differ significantly between participants with low and
high degrees of insulin resistance, while differences in vBMD of the third lumbar vertebra and CTx-1
are of marginal statistical significance.
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